ZFYVE16 Antibody [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-36538B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation, Western Blot
Label
Biotin
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ZFYVE16 Antibody [Biotin]
Immunogen
The immunogen recognized by the antibody maps to a region between residue 450 to 500 of human Endosome-Associated FYVE Domain Protein using the numbering given in entry NP_001098721.1.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ZFYVE16 Antibody [Biotin]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ZFYVE16
Alternate Names
DKFZp686E13162, Endofin, endosome-associated FYVE-domain protein, KIAA0305Endosome-associated FYVE domain protein, zinc finger FYVE domain-containing protein 16, zinc finger, FYVE domain containing 16
Gene Symbol
ZFYVE16
Additional ZFYVE16 Products
Product Documents for ZFYVE16 Antibody [Biotin]
Product Specific Notices for ZFYVE16 Antibody [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...